Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21)
Funds the same reanalysis of already-collected cancer data on a smaller, exploratory footing, for teams that do not need a full research project award.
This is the exploratory twin of the National Cancer Institute's secondary-analysis notice. Same question, same data, less money and a shorter horizon.
The scope does not change. Clinical, environmental, surveillance, health services, vital statistics, behavioural, lifestyle, genomic and molecular data that already exists, analysed to say more about cancer risk, risk reduction, survival or respons…
Exploratory secondary analysis and integration of existing clinical, environmental, surveillance, health services, vital statistics, behavioural, lifestyle, genomic and molecular datasets to elucidate cancer risk, risk reduction, survival and treatment response. Clinical trials are not allowed.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up